7-{[(2,2,2,-Trichloroethyl)oxy]carbonyl} Paclitaxel-d5

7-{[(2,2,2,-Trichloroethyl)oxy]carbonyl} Paclitaxel-d5 is a chemical compound that is used in the treatment of cancer. It is a derivative of Paclitaxel, a natural product that is extracted from the bark of the Pacific yew tree. The compound is labeled with deuterium atoms at specific positions, which makes it useful for pharmacokinetic studies. The compound is administered by injection and is used to treat a variety of cancers, including breast, ovarian, lung, and prostate cancer. It works by inhibiting the growth and division of cancer cells, thereby preventing the spread of the disease. The chemical formula of 7-{[(2,2,2,-Trichloroethyl)oxy]carbonyl} Paclitaxel-d5 is C47H48Cl3NO14 and it has a molecular weight of 985.27 g/mol. The compound is a white to off-white powder that is soluble in organic solvents such as methanol, ethanol, and dimethyl sulfoxide. It is important to note that 7-{[(2,2,2,-Trichloroethyl)oxy]carbonyl} Paclitaxel-d5 is a potent cytotoxic agent and should only be administered by trained healthcare professionals. It may cause side effects such as nausea, vomiting, hair loss, and fatigue. Patients should be closely monitored during treatment and appropriate measures should be taken to manage any adverse effects. In conclusion, 7-{[(2,2,2,-Trichloroethyl)oxy]carbonyl} Paclitaxel-d5 is a useful tool in cancer research and treatment. Its unique chemical properties make it valuable for pharmacokinetic studies, and it has shown promising results in the treatment of various types of cancer.